Evidence map›Paper›PMID 32227073›Full record

ReviewJornal brasileiro de nefrologia2020

Early Hospital Readmission (EHR) in kidney transplantation: a review article.

Melissa Gaspar Tavares, Helio Tedesco-Silva Junior, Jose Osmar Medina Pestana

Open access · diamondAbstract readReview
In one paragraph

Review in Jornal brasileiro de nefrologia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Melissa Gaspar TavaresUniversidade Federal de São Paulo, Hospital do Rim, São Paulo, SP, Brasil.ORCID http://orcid.org/0000-0001-6908-1927
Helio Tedesco-Silva JuniorUniversidade Federal de São Paulo, Hospital do Rim, São Paulo, SP, Brasil.ORCID http://orcid.org/0000-0002-9896-323X
Jose Osmar Medina PestanaUniversidade Federal de São Paulo, Hospital do Rim, São Paulo, SP, Brasil.ORCID http://orcid.org/0000-0002-0750-7360
Hospital do Rim e Hipertensão · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early hospital readmission (EHR), defined as all readmissions within 30 days of initial hospital discharge, is a health care quality measure. It is influenced by the demographic characteristics of the population at risk, the multidisciplinary approach for hospital discharge, the access, coverage, and comprehensiveness of the health care system, and reimbursement policies. EHR is associated with higher morbidity, mortality, and increased health care costs. Monitoring EHR enables the identification of hospital and outpatient healthcare weaknesses and the implementation of corrective interventions. Among kidney transplant recipients in the USA, EHR ranges between 18 and 47%, and is associated with one-year increased mortality and graft loss. One study in Brazil showed an incidence of 19.8% of EHR. The main causes of readmission were infections and surgical and metabolic complications. Strategies to reduce early hospital readmission are therefore essential and should consider the local factors, including socio-economic conditions, epidemiology and endemic diseases, and mobility.

Indexed as

AdultBrazilDelivery of Health CareFemaleFollow-Up StudiesGraft SurvivalHumansIncidenceInfectionsInsurance, Health, ReimbursementInterdisciplinary CommunicationKidney TransplantationMaleMetabolic DiseasesMiddle AgedPatient Discharge

Identifiers

PMID32227073
PMCPMC7427637
OpenAlexW3013500070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.